Answer
From pregnancy week 20 onward, VIMOVO may reduce amniotic fluid through foetal renal dysfunction, potentially soon after starting and usually reversibly after stopping; monitoring should be considered after several days’ exposure, and VIMOVO should be discontinued if oligohydramnios is found.
Sources for this answer
- VIMOVO 500 mg/20 mg modified-release tabletsGrunenthal Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 21Document updated
Sources checked